Ohtuvayre® (ensifentrine) - Correct Coding and Coverage - Revised

Ohtuvayre® (ensifentrine) is an inhalation solution approved by the U.S. Food and Drug Administration on June 26, 2024 and is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients.